Table 3 Absolute changes in GLS, segmental strain and estimated LVEF% after receiving antiviral treatment between studied groups

LVEF%

0.68 ± 0.98

0.53 ± 0.4

0.184

GLS

1.13 ± 0.21

0.47 ± 0.24

0.036

Basal anterior

1.12 ± 8.06

0.65 ± 3

0.031

Basal anteroseptal

1.06 ± 3.32

0.58 ± 2.35

0.014

Basal anterolateral

1.3 ± 6.04

0.75 ± 3.65

0.045

Basal inferior

1.39 ± 7.34

0.6 ± 4.05

0.039

Basal inferoseptal

1.22 ± 4.98

0.59 ± 5.77

0.028

Basal inferolateral

1.07 ± 5.81

0.38 ± 4.01

0.016

Mid anterior

1.29 ± 7.41

0.55 ± 3.12

0.022

Mid anteroseptal

1.17 ± 9.84

0.4 ± 6

0.035

Mid anterolateral

1.08 ± 3.86

0.48 ± 4.85

0.034

Mid inferior

1.15 ± 6.17

0.6 ± 3.78

0.042

Mid inferoseptal

1.18 ± 5.42

0.53 ± 4.11

0.024

Mid inferolateral

1.03 ± 6.14

0.4 ± 4.63

0.025

Apical anterior

1.07 ± 12.83

0.45 ± 4.77

0.037

Apical septal

1.06 ± 7.18

0.51 ± 4.25

0.046

Apical inferior

1.12 ± 8.69

0.45 ± 2.87

0.036

Apical lateral

1.14 ± 8.83

0.35 ± 4.39

0.025